Judith A. Kantor

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

James W. Hodge, Joanne P. McLaughlin, Judith A. Kantor et al. · Vaccine · 1997 · 202 citations

Vaccination, Vaccine Development, Medicine +11

Beta thalassemia: Mutations which affect processing of the β-globin mRNA precursor

Judith A. Kantor, Patricia H. Turner, Arthur W. Nienhuis · Cell · 1980 · 101 citations

Beta Thalassemia, β-Globin Mrna Precursor, Genetics +6

Generation of Stable CD4+and CD8+T Cell Lines from Patients Immunized withrasOncogene-Derived Peptides Reflecting Codon 12 Mutations

Scott I. Abrams, Samir N. Khleif, Elke S. Bergmann‐Leitner et al. · Cellular Immunology · 1997 · 91 citations

Immunogenetics, Autoimmune Disease, Adaptive Immune System +8

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Fiorella Guadagni, Judith A. Kantor, Simona Aloe et al. · PubMed · 2001 · 76 citations

Nucleic Acid Biomarkers, Cancer Detection, Medicine +13

Therapeutic Antitumor Response After Immunization with an Admixture of Recombinant Vaccinia Viruses Expressing a Modified MUC1 Gene and the Murine T-Cell Costimulatory Molecule B7

Junji Akagi, James W. Hodge, Joanne P. McLaughlin et al. · Journal of Immunotherapy · 1997 · 66 citations

Immunology, Pathology, Immunotherapy +19